Brand Watch: Three companies put their impacts on nature under a microscope. Here’s what they found
Look deep into nature and then you will understand everything better.” The quote from Albert Einstein is generally deployed ...
GSK rises Monday, outperforms market
GSK PLC GSK shares advanced 3.35% to £14.02 Monday, on what proved to be an all-around great trading session for the stock ...
GlobalData on MSN1d
GSK and University of Oxford partner for cancer vaccine research
GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...
pharmaphorum4d
What makes GSK the number one pharmaceutical company in Egypt?
GSK has understood the game of access in Egypt earlier than other companies. By buying two successful local manufacturing facilities with their generic brands, GSK has better market access than ...
FierceBiotech6d
GSK, Merck and Pfizer in Ab&B's sights as Chinese vaccine biotech files for IPO
Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...
New Strong Sell Stocks for January 23rd
Arcos Dorados Holdings Inc. ARCO is a franchisee of McDonald’s restaurants. The Zacks Consensus Estimate for its current year ...
FierceBiotech2d
GSK offers up to £50M to conduct cancer vaccine research with the University of Oxford
British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work ...
MarketWatch1mon
GSK falls Friday, underperforms market
GSK PLC GSK shares inched down 0.34% to £13.30 Friday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100 Index UKX falling 0.14% to 8,300.33 ...
Hosted on MSN1mon
Relation-GSK to drive fibrotic and osteoarthritis developments
"Relation-GSK to drive fibrotic and osteoarthritis developments" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been ...